Equasens
Company Profile
- Business description- Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available. 
- Contact- 5 Allee de Saint-Cloud 
 Technopole de Nancy Brabois
 Villers-les-Nancy54600
 FRA- T: +33 383159595 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Health Information Services - Fiscal Year End- 31 December 2025 - Employees- 817 
Stocks News & Analysis
stocks
Microsoft earnings: Strong, including Azure, but overall guidance is in line
stocks
After earnings, is Tesla stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,178.00 | 28.70 | -0.31% | 
| CAC 40 | 8,108.76 | 92.12 | -1.12% | 
| DAX 40 | 23,949.74 | 169.15 | -0.70% | 
| Dow JONES (US) | 47,510.71 | 11.41 | -0.02% | 
| FTSE 100 | 9,707.37 | 52.69 | -0.54% | 
| HKSE | 25,906.65 | 376.04 | -1.43% | 
| NASDAQ | 23,754.41 | 173.26 | 0.73% | 
| Nikkei 225 | 52,411.34 | 1,085.73 | 2.12% | 
| NZX 50 Index | 13,548.32 | 89.03 | 0.66% | 
| S&P 500 | 6,842.07 | 19.73 | 0.29% | 
| S&P/ASX 200 | 8,881.90 | 31.30 | -0.35% | 
| SSE Composite Index | 3,954.79 | 32.11 | -0.81% |